GSK PLC (GSK)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

2,098.00p

Buy

2,099.00p

arrow-up35.00p (+1.70%)

Prices updated at 01 Apr 2026, 15:54 BST

Prices minimum 15 mins delay

Prices in GBX

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.

FTSE All-Share

1.71%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	31,376m	32,667m
	22,328m	23,650m
	5,542m	8,338m
	17.66	25.52
	2,575m	5,716m
	6,668m	10,402m
Sales, General and administrative	11,015m	9,088m
Interest expenses	640m	687m
Provision for income taxes	526m	1,112m
Operating expenses	16,786m	15,312m
Income before taxes	3,477m	7,401m
Net income available to common shareholders	2,575m	5,716m
	0.632	1.411
Net interest income	-603m	-633m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.622	1.388
Free cash flow per share	1.1593	1.1356
Book value/share	3.4326	4.0244
Debt equity ratio	1.070661	0.898089

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	16,997m	17,510m
Current liabilities	21,697m	21,391m
Total capital	27,374m	30,392m
Total debt	16,986m	17,720m
Total equity	13,671m	16,377m
Total non current liabilities	-	-
Loans	13,703m	14,015m
Total assets	59,463m	61,118m
Total liabilities	-	-
Cash and cash equivalents	3,693m	3,150m
Common stock	4,081m	4,013m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	2,858m	3,403m
Cash dividends paid	-2,444m	-2,564m
	3,572m	4,756m
Investments (gains) losses	-1,229m	-4,233m
	3,403m	3,207m
Net income	-	-
	6,554m	7,741m
	-2,982m	-2,985m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.